/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Masimo (MASI) shares ended their recent session up about 35% after science and technology giant Danaher (DHR) announced a definitive agreement to acquire the health tech firm.
For Masimo, this $9.9 billion all-cash deal means global scale, integration into DHR’s huge distribution network, and institutional backing to defend its IP against tech titans like Apple (AAPL).